Inflammatory responses and intestinal injury development during acute Trypanosoma cruzi infection are associated with the parasite load

[1]  L. Sánchez-Magraner,et al.  Seroprevalence of Triatoma virus (Dicistroviridae: Cripaviridae) antibodies in Chagas disease patients , 2015, Parasites & Vectors.

[2]  W. Monteiro,et al.  Comparative pathogenicity in Swiss mice of Trypanosoma cruzi IV from northern Brazil and Trypanosoma cruzi II from southern Brazil. , 2014, Experimental parasitology.

[3]  D. Steverding.  The history of Chagas disease , 2014, Parasites & Vectors.

[4]  R. Corrêa-Oliveira,et al.  Plasma Cytokine Expression Is Associated with Cardiac Morbidity in Chagas Disease , 2014, PloS one.

[5]  C. Carneiro,et al.  Myenteric plexus is differentially affected by infection with distinct Trypanosoma cruzi strains in Beagle dogs , 2013, Memorias do Instituto Oswaldo Cruz.

[6]  P. C. Pereira,et al.  Challenges and perspectives of Chagas disease: a review , 2013, Journal of Venomous Animals and Toxins including Tropical Diseases.

[7]  A. Prata,et al.  Length and caliber of the rectosigmoid colon among patients with Chagas disease and controls from areas at different altitudes. , 2013, Revista da Sociedade Brasileira de Medicina Tropical.

[8]  R. Parreira,et al.  Influence of Parasite Load on Renal Function in Mice Acutely Infected with Trypanosoma cruzi , 2013, PloS one.

[9]  J. Ramírez,et al.  Identification of Trypanosoma cruzi Discrete Typing Units (DTUs) through the implementation of a High-Resolution Melting (HRM) genotyping assay , 2013, Parasites & Vectors.

[10]  M. C. Nunes,et al.  High interleukin 17 expression is correlated with better cardiac function in human Chagas disease. , 2013, The Journal of infectious diseases.

[11]  J. E. Lazo Chica,et al.  Different parasite inocula determine the modulation of the immune response and outcome of experimental Trypanosoma cruzi infection , 2013, Immunology.

[12]  M. Teixeira,et al.  Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease , 2012, Seminars in Immunopathology.

[13]  C. Alencar,et al.  Mortality Related to Chagas Disease and HIV/AIDS Coinfection in Brazil , 2012, Journal of tropical medicine.

[14]  B. Maciel,et al.  Deficient Regulatory T Cell Activity and Low Frequency of IL-17-Producing T Cells Correlate with the Extent of Cardiomyopathy in Human Chagas' Disease , 2012, PLoS neglected tropical diseases.

[15]  E. Crema,et al.  Research on Trypanosoma cruzi and Analysis of Inflammatory Infiltrate in Esophagus and Colon from Chronic Chagasic Patients with and without Mega , 2011, Journal of tropical medicine.

[16]  María Clara Grande López,et al.  Enfermedad de Chagas en el diagnóstico diferencial del megacolon , 2011 .

[17]  M. Gomes,et al.  Neuronal changes caused by Trypanosoma cruzi: an experimental model. , 2011, Anais da Academia Brasileira de Ciencias.

[18]  Y. Carlier,et al.  Parasitic Loads in Tissues of Mice Infected with Trypanosoma cruzi and Treated with AmBisome , 2011, PLoS neglected tropical diseases.

[19]  V. Rodrigues,et al.  Genetic and Functional Role of TNF-alpha in the Development Trypanosoma cruzi Infection , 2011, PLoS neglected tropical diseases.

[20]  A. Pallisera,et al.  Chagas disease in the differential diagnosis of megacolon. , 2011, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[21]  Y. Iwakura,et al.  IL-17 Is Necessary for Host Protection against Acute-Phase Trypanosoma cruzi Infection , 2010, The Journal of Immunology.

[22]  J. Silva,et al.  IL-17 Produced during Trypanosoma cruzi Infection Plays a Central Role in Regulating Parasite-Induced Myocarditis , 2010, PLoS neglected tropical diseases.

[23]  A. Romanha,et al.  A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. , 2009, Memorias do Instituto Oswaldo Cruz.

[24]  E. Chiari,et al.  Immunological imbalance between IFN-gamma and IL-10 levels in the sera of patients with the cardiac form of Chagas disease. , 2009, Memorias do Instituto Oswaldo Cruz.

[25]  L. Weiss,et al.  A magnetic resonance imaging study of intestinal dilation in Trypanosoma cruzi-infected mice deficient in nitric oxide synthase. , 2008, The American journal of tropical medicine and hygiene.

[26]  J. Altclas,et al.  Chagas disease in bone marrow transplantation: an approach to preemptive therapy , 2005, Bone Marrow Transplantation.

[27]  M. Rossi,et al.  Interferon-gamma-induced nitric oxide causes intrinsic intestinal denervation in Trypanosoma cruzi-infected mice. , 2004, The American journal of pathology.

[28]  S. D. Pena,et al.  Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of chagas disease. , 2004, Memorias do Instituto Oswaldo Cruz.

[29]  A Prata,et al.  Clinical and epidemiological aspects of Chagas disease. , 2001, The Lancet. Infectious diseases.

[30]  R. M. Etchebehere,et al.  Neuron count reevaluation in the myenteric plexus of chagasic megacolon after morphometric neuron analysis , 2001, Virchows Archiv.

[31]  H. Castro-Faria-Neto,et al.  Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages , 2000, Nature.

[32]  Elio Moreno,et al.  Efecto de inóculos bajos en la infección experimental por trypanosoma cruzi , 1999 .

[33]  M. Grisotto,et al.  Influence of Acute-Phase Parasite Load on Pathology, Parasitism, and Activation of the Immune System at the Late Chronic Phase of Chagas’ Disease , 1999, Infection and Immunity.

[34]  E. Chapadeiro.  Clinical evolution and morbi-mortality in Chagas disease. , 1999, Memorias do Instituto Oswaldo Cruz.

[35]  T. Slifer,et al.  IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. , 1997, Journal of immunology.

[36]  S. G. Andrade,et al.  Biodemes and zymodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology. , 1997, Revista da Sociedade Brasileira de Medicina Tropical.

[37]  R. Coffman,et al.  Trypanosoma cruzi:IL-10, TNF, IFN-γ, and IL-12 Regulate Innate and Acquired Immunity to Infection , 1996 .

[38]  S. Ekşi,et al.  Host genetics and resistance to acute Trypanosoma cruzi infection in mice: profiles and compartmentalization of IL-2-, -4-, -5-, -10-, and IFN-gamma-producing cells. , 1996, The Journal of parasitology.

[39]  L. Glimcher,et al.  Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. , 1996, International immunology.

[40]  M. Rossi.  Pathogenesis of chronic Chagas' myocarditis. , 1995, Sao Paulo medical journal = Revista paulista de medicina.

[41]  S. Reed,et al.  Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection , 1992, The Journal of experimental medicine.

[42]  R. Tarleton,et al.  Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection. , 1991, Journal of immunology.

[43]  S. Zucoloto,et al.  Morphometric investigations of the colon mucosa in chronicTrypanosoma cruzi infected rats , 1991, Virchows Archiv. B, Cell pathology including molecular pathology.

[44]  A. Prata.  Classificação da infecção chagásica no homem , 1990 .

[45]  B. Morson,et al.  Chagas disease of the colon and rectum , 1969, Gut.

[46]  F. Köberle.  Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis. , 1968, Advances in parasitology.

[47]  Z. Brener.  Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. , 1962, Revista do Instituto de Medicina Tropical de Sao Paulo.

[48]  Carlos Chagas,et al.  Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem , 1909 .